Give Hope Blog

breakthroughs - betty ferrell headshot

End-of-Life nursing education program expands to 100 countries

May 7, 2019 | Michael Easterling

The End-of-Life Nursing Education Consortium (ELNEC) curricula developed by City of Hope nurses is now available and has been shared in its 100th country, Bulgaria.

Continue Reading

AML | City of Hope

City of Hope investigates a novel therapeutic approach in AML

April 26, 2019 | City of Hope

City of Hope opens recruitment for a phase I/II dose-finding study of novel agent 8-chloro-adenosine in patients with relapsed/refractory acute myeloid leukemia.

Continue Reading

Blood Cancer | City of Hope

City of Hope launches first CAR T cell trial targeting CS1 protein in multiple myeloma

April 26, 2019 | City of Hope

City of Hope is now enrolling relapsed/refractory multiple myeloma patients for a first-of-its kind chimeric antigen receptor T cell therapy phase I trial.

Continue Reading

breakthroughs - arthur riggs

International diabetes experts converge for Levine-Riggs symposium

April 23, 2019 | Michael Easterling

More than 250 physicians and scientists from around the world attended the 2019 City of Hope Levine-Riggs Diabetes Research Symposium, held April 10 to 13 at The Westin Hotel in Pasadena, California.

Continue Reading

cancer cell

TGen IDs gene associated with most common liver cancer

April 19, 2019 | City of Hope

AKR1B10 could help provide early detection of hepatocellular carcinoma, and play a role in monitoring and treating this growing cause of cancer death.

Continue Reading

children and sunscreen

People miss key area of face with sunscreen products, study finds

April 11, 2019 | Samantha Bonar

People commonly miss their eyelids when applying sunscreen or moisturizers containing SPF. This is of concern because this fragile area is prone to skin cancer.

Continue Reading

Christiane Querfeld, M.D., Ph.D.

City of Hope awarded $7.5M to develop treatment for rare cancer

April 3, 2019 | Zen Vuong

City of Hope recently received $7.5 million in grant awards to study a rare type of blood cancer that affects the skin: cutaneous T cell lymphoma.

Continue Reading

Back To Top